Feline Infectious Peritonitis (FIP) was historically a fatal disease causing significant suffering, but antiviral treatments developed in 2019-2021 have transformed it from a death sentence to a treatable condition.
Before effective antiviral treatment, FIP caused progressive debilitation through either fluid accumulation (wet form) or progressive inflammatory organ damage (dry form) — with suffering extending over weeks to months before death. The transformation in FIP welfare outcomes through antiviral treatment is one of the most dramatic in recent feline medicine. Cats that would have died are now recovering and returning to normal lives. The main current welfare challenge is ensuring access to treatment — the medication is costly and in some countries still not formally licensed for veterinary use, creating access barriers. Early diagnosis is critical because treatment is more successful before advanced disease. Welfare-conscious feline medicine requires awareness of FIP presentation and prompt diagnostic workup of suspected cases.